Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined

Journal of Immunology

Volumn 190, Issue 5, 2013, Pages 2058-2067

  Dillahunt, Sandra E ^a   Sargent, Jennifer L ^a   Suzuki, Ryo ^a   Proia, Richard L ^b   Gilfillan, Alasdair ^c   Rivera, Juan ^a   Olivera, Ana ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; SHORT HAIRPIN RNA; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CELL TYPE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE SILENCING; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPECIES DIFFERENCE;

ANIMALS; CALCIUM; CELL DEGRANULATION; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC VECTORS; HUMANS; ISOENZYMES; LENTIVIRUS; LEUKOTRIENES; LYSOPHOSPHOLIPIDS; MAST CELLS; MICE; ORGAN SPECIFICITY; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, IGE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPHINGOSINE; TRANSDUCTION, GENETIC;

EID: 84874237967     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201503     Document Type: Article

References (63)

1. Taha, T. A., Y. A. Hannun, and L. M. Obeid. 2006. Sphingosine kinase: biochemical and cellular regulation and role in disease. J. Biochem. Mol. Biol. 39: 113-131.
2. Hla, T. 2004. Physiological and pathological actions of sphingosine 1-phosphate. Semin. Cell Dev. Biol. 15: 513-520.
3. Camerer, E., J. B. Regard, I. Cornelissen, Y. Srinivasan, D. N. Duong, D. Palmer, T. H. Pham, J. S. Wong, R. Pappu, and S. R. Coughlin. 2009. Sphingosine-1- phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Invest. 119: 1871-1879.
4. Schwab, S. R., and J. G. Cyster. 2007. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 8: 1295-1301.
5. Rivera, J., R. L. Proia, and A. Olivera. 2008. The alliance of sphingosine-1- phosphate and its receptors in immunity. Nat. Rev. Immunol. 8: 753-763.
6. Aktas, O., P. Küry, B. Kieseier, and H. P. Hartung. 2010. Fingolimod is a potential novel therapy for multiple sclerosis. Nat Rev Neurol 6: 373-382.
7. Obinata, H., and T. Hla. 2012. Sphingosine 1-phosphate in coagulation and inflammation. Semin. Immunopathol. 34: 73-91.
8. Pyne, N. J., and S. Pyne. 2010. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 10: 489-503.
9. Spiegel, S., and S. Milstien. 2011. The outs and the ins of sphingosine-1- phosphate in immunity. Nat. Rev. Immunol. 11: 403-415.
10. Olivera, A., and J. Rivera. 2011. An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease. Adv. Exp. Med. Biol. 716: 123-142.
11. Olivera, A. 2008. Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model. Prostaglandins Other Lipid Mediat. 86: 1-11.
12. Pitson, S. M. 2011. Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem. Sci. 36: 97-107.
13. Maceyka, M., H. Sankala, N. C. Hait, H. Le Stunff, H. Liu, R. Toman, C. Collier, M. Zhang, L. S. Satin, A. H. Merrill, Jr., et al. 2005. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem. 280: 37118-37129.
14. Alemany, R., C. J. van Koppen, K. Danneberg, M. Ter Braak, and D. Meyer Zu Heringdorf. 2007. Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch. Pharmacol. 374: 413-428.
15. Billich, A., F. Bornancin, P. Dévay, D. Mechtcheriakova, N. Urtz, and T. Baumruker. 2003. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 278: 47408-47415.
16. Kihara, A., Y. Anada, and Y. Igarashi. 2006. Mouse sphingosine kinase isoforms SPHK1a and SPHK1b differ in enzymatic traits including stability, localization, modification, and oligomerization. J. Biol. Chem. 281: 4532-4539.
17. Okada, T., G. Ding, H. Sonoda, T. Kajimoto, Y. Haga, A. Khosrowbeygi, S. Gao, N. Miwa, S. Jahangeer, and S. Nakamura. 2005. Involvement of N-terminalextended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J. Biol. Chem. 280: 36318-36325.
18. Venkataraman, K., S. Thangada, J. Michaud, M. L. Oo, Y. Ai, Y. M. Lee, M. Wu, N. S. Parikh, F. Khan, R. L. Proia, and T. Hla. 2006. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem. J. 397: 461-471.
19. Galli, S. J., and M. Tsai. 2008. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J. Dermatol. Sci. 49: 7-19.
20. Rivera, J., and A. Olivera. 2007. Src family kinases and lipid mediators in control of allergic inflammation. Immunol. Rev. 217: 255-268.
21. Olivera, A., K. Mizugishi, A. Tikhonova, L. Ciaccia, S. Odom, R. L. Proia, and J. Rivera. 2007. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26: 287-297.
22. Olivera, A., N. Urtz, K. Mizugishi, Y. Yamashita, A. M. Gilfillan, Y. Furumoto, H. Gu, R. L. Proia, T. Baumruker, and J. Rivera. 2006. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J. Biol. Chem. 281: 2515-2525.
23. Prieschl, E. E., R. Csonga, V. Novotny, G. E. Kikuchi, and T. Baumruker. 1999. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc ε receptor I triggering. J. Exp. Med. 190: 1-8.
24. Choi, O. H., J. H. Kim, and J. P. Kinet. 1996. Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor. Nature 380: 634-636.
25. Jolly, P. S., M. Bektas, A. Olivera, C. Gonzalez-Espinosa, R. L. Proia, J. Rivera, S. Milstien, and S. Spiegel. 2004. Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199: 959-970.
26. Melendez, A. J., and A. K. Khaw. 2002. Dichotomy of Ca2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J. Biol. Chem. 277: 17255-17262.
27. Mitra, P., C. A. Oskeritzian, S. G. Payne, M. A. Beaven, S. Milstien, and S. Spiegel. 2006. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc. Natl. Acad. Sci. USA 103: 16394-16399.
28. Ammit, A. J., A. T. Hastie, L. C. Edsall, R. K. Hoffman, Y. Amrani, V. P. Krymskaya, S. A. Kane, S. P. Peters, R. B. Penn, S. Spiegel, and R. A. Panettieri, Jr. 2001. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 15: 1212-1214.
29. Kitano, M., T. Hla, M. Sekiguchi, Y. Kawahito, R. Yoshimura, K. Miyazawa, T. Iwasaki, H. Sano, J. D. Saba, and Y. Y. Tam. 2006. Sphingosine 1-phosphate/ sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum. 54: 742-753.
30. Jolly, P. S., M. Bektas, K. R. Watterson, H. Sankala, S. G. Payne, S. Milstien, and S. Spiegel. 2005. Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors. Blood 105: 4736-4742.
31. Oskeritzian, C. A., S. E. Alvarez, N. C. Hait, M. M. Price, S. Milstien, and S. Spiegel. 2008. Distinct roles of sphingosine kinases 1 and 2 in human mastcell functions. Blood 111: 4193-4200.
32. Pushparaj, P. N., J. Manikandan, H. K. Tay, S. C. H'ng, S. D. Kumar, J. Pfeilschifter, A. Huwiler, and A. J. Melendez. 2009. Sphingosine kinase 1 is pivotal for Fc epsilon RI-mediated mast cell signaling and functional responses in vitro and in vivo. J. Immunol. 183: 221-227.
33. Allende, M. L., T. Sasaki, H. Kawai, A. Olivera, Y. Mi, G. van Echten-Deckert, R. Hajdu, M. Rosenbach, C. A. Keohane, S. Mandala, et al. 2004. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279: 52487-52492.
34. Mizugishi, K., T. Yamashita, A. Olivera, G. F. Miller, S. Spiegel, and R. L. Proia. 2005. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25: 11113-11121.
35. Saitoh, S., R. Arudchandran, T. S. Manetz, W. Zhang, C. L. Sommers, P. E. Love, J. Rivera, and L. E. Samelson. 2000. LAT is essential for Fc(epsilon) RI-mediated mast cell activation. Immunity 12: 525-535.
36. Charles, N., W. T. Watford, H. L. Ramos, L. Hellman, H. C. Oettgen, G. Gomez, J. J. Ryan, J. J. O'Shea, and J. Rivera. 2009. Lyn kinase controls basophil GATA- 3 transcription factor expression and induction of Th2 cell differentiation. Immunity 30: 533-543.
37. Hershko, A. Y., R. Suzuki, N. Charles, D. Alvarez-Errico, J. L. Sargent, A. Laurence, and J. Rivera. 2011. Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis. Immunity 35: 562-571.
38. Radinger, M., B. M. Jensen, H. S. Kuehn, A. Kirshenbaum, and A. M. Gilfillan. 2010. Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood. Curr. Protoc. Immunol. Chapter 7: Unit 7.37.
39. Liu, F. T., J. W. Bohn, E. L. Ferry, H. Yamamoto, C. A. Molinaro, L. A. Sherman, N. R. Klinman, and D. H. Katz. 1980. Monoclonal dinitrophenylspecific murine IgE antibody: preparation, isolation, and characterization. J. Immunol. 124: 2728-2737.
40. Kuehn, H. S., M. Radinger, and A. M. Gilfillan. 2010. Measuring mast cell mediator release. Curr. Protoc. Immunol. Chapter 7: Unit 7.38.
41. Olivera, A., C. Eisner, Y. Kitamura, S. Dillahunt, L. Allende, G. Tuymetova, W. Watford, F. Meylan, S. C. Diesner, L. Li, et al. 2010. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J. Clin. Invest. 120: 1429-1440.
42. Suzuki, R., X. Liu, A. Olivera, L. Aguiniga, Y. Yamashita, U. Blank, I. Ambudkar, and J. Rivera. 2010. Loss of TRPC1-mediated Ca2+ influx contributes to impaired degranulation in Fyn-deficient mouse bone marrow-derived mast cells. J. Leukoc. Biol. 88: 863-875.
43. Galli, S. J., N. Borregaard, and T. A. Wynn. 2011. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12: 1035-1044.
44. Moon, T. C., C. D. St Laurent, K. E. Morris, C. Marcet, T. Yoshimura, Y. Sekar, and A. D. Befus. 2010. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol. 3: 111-128.
45. Malbec, O., K. Roget, C. Schiffer, B. Iannascoli, A. R. Dumas, M. Arock, and M. Daëron. 2007. Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells. J. Immunol. 178: 6465-6475.
46. Liu, H., D. Chakravarty, M. Maceyka, S. Milstien, and S. Spiegel. 2002. Sphingosine kinases: a novel family of lipid kinases. Prog. Nucleic Acid Res. Mol. Biol. 71: 493-511.
47. Ryu, S. D., H. S. Lee, H. Y. Suk, C. S. Park, and O. H. Choi. 2009. Cross-linking of FcepsilonRI causes Ca2+ mobilization via a sphingosine kinase pathway in a clathrin-dependent manner. Cell Calcium 45: 99-108.
48. Collington, S. J., T. J. Williams, and C. L. Weller. 2011. Mechanisms underlying the localisation of mast cells in tissues. Trends Immunol. 32: 478-485.
49. Ishizuka, T., F. Okajima, M. Ishiwara, K. Iizuka, I. Ichimonji, T. Kawata, H. Tsukagoshi, K. Dobashi, T. Nakazawa, and M. Mori. 2001. Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase. J. Immunol. 167: 2298-2304.
50. Kirshenbaum, A. S., C. Akin, Y. Wu, M. Rottem, J. P. Goff, M. A. Beaven, V. K. Rao, and D. D. Metcalfe. 2003. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk. Res. 27: 677-682.
51. Urtz, N., A. Olivera, E. Bofill-Cardona, R. Csonga, A. Billich, D. Mechtcheriakova, F. Bornancin, M. Woisetschläger, J. Rivera, and T. Baumruker. 2004. Early activation of sphingosine kinase in mast cells and recruitment to FcepsilonRI are mediated by its interaction with Lyn kinase. Mol. Cell. Biol. 24: 8765-8777.
52. Hengst, J. A., J. M. Guilford, T. E. Fox, X. Wang, E. J. Conroy, and J. K. Yun. 2009. Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibition. Arch. Biochem. Biophys. 492: 62-73.
53. Sankala, H. M., N. C. Hait, S. W. Paugh, D. Shida, S. Lépine, L. W. Elmore, P. Dent, S. Milstien, and S. Spiegel. 2007. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Res. 67: 10466-10474.
54. Don, A. S., and H. Rosen. 2009. A lipid binding domain in sphingosine kinase 2. Biochem. Biophys. Res. Commun. 380: 87-92.
55. Hait, N. C., S. Sarkar, H. Le Stunff, A. Mikami, M. Maceyka, S. Milstien, and S. Spiegel. 2005. Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J. Biol. Chem. 280: 29462-29469.
56. Hait, N. C., A. Bellamy, S. Milstien, T. Kordula, and S. Spiegel. 2007. Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J. Biol. Chem. 282: 12058-12065.
57. Karliner, J. S. 2009. Sphingosine kinase regulation and cardioprotection. Cardiovasc. Res. 82: 184-192.
58. Vessey, D. A., L. Li, Z. Q. Jin, M. Kelley, N. Honbo, J. Zhang, and J. S. Karliner. 2011. A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning. Oxid. Med. Cell. Longev. 2011: 961059.
59. Van Brocklyn, J. R., C. A. Jackson, D. K. Pearl, M. S. Kotur, P. J. Snyder, and T. W. Prior. 2005. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J. Neuropathol. Exp. Neurol. 64: 695-705.
60. Nemoto, S., M. Nakamura, Y. Osawa, S. Kono, Y. Itoh, Y. Okano, T. Murate, A. Hara, H. Ueda, Y. Nozawa, and Y. Banno. 2009. Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. J. Biol. Chem. 284: 10422-10432.
61. Diesner, S. C., A. Olivera, S. Dillahunt, C. Schultz, T. Watzlawek, E. Förster- Waldl, A. Pollak, E. Jensen-Jarolim, E. Untersmayr, and J. Rivera. 2012. Sphingosine-kinase 1 and 2 contribute to oral sensitization and effector phase in a mouse model of food allergy. Immunol. Lett. 141: 210-219.
62. Zhao, W., C. L. Kepley, P. A. Morel, L. M. Okumoto, Y. Fukuoka, and L. B. Schwartz. 2006. Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells. J. Immunol. 177: 694-701.
63. Bischoff, S. C. 2007. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol. 7: 93-104.